mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland

Publication

mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland

Journal Paper/Review - Jan 20, 2022

Hilty Matthias Peter, Keiser Stefanie, Wendel Garcia Pedro D, Moser André, Schuepbach Reto A, RISC-19-ICU Investigators for Switzerland, Kleger Gian-Reto

Citation

Hilty M, Keiser S, Wendel Garcia P, Moser A, Schuepbach R, RISC-19-ICU Investigators for Switzerland, Kleger G. mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland. Intensive Care Med 2022

Type

Journal Paper/Review (English)

Journal

Intensive Care Med 2022

Publication Date

Jan 20, 2022

Issn Electronic

1432-1238